JPY 3460.0
(2.37%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 2.33 Billion JPY | 37.63% |
2022 | 1.69 Billion JPY | 22.47% |
2021 | 1.38 Billion JPY | 47.91% |
2020 | 934.83 Million JPY | 15.84% |
2019 | 806.97 Million JPY | 31.94% |
2018 | 611.62 Million JPY | -4.09% |
2017 | 637.68 Million JPY | 144.68% |
2016 | 260.62 Million JPY | 48.87% |
2015 | 175.06 Million JPY | -20.57% |
2014 | 220.39 Million JPY | 80.08% |
2013 | 122.38 Million JPY | 66.44% |
2012 | 73.53 Million JPY | 38.13% |
2011 | 53.23 Million JPY | 55.96% |
2010 | 34.13 Million JPY | 0.0% |
2008 | 78.9 Million JPY | -30.33% |
2007 | 113.26 Million JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 2.49 Billion JPY | 7.12% |
2024 Q2 | 2.97 Billion JPY | 19.21% |
2023 Q1 | 1.7 Billion JPY | 0.89% |
2023 Q4 | 2.33 Billion JPY | 48.09% |
2023 Q3 | 1.57 Billion JPY | -6.52% |
2023 Q2 | 1.68 Billion JPY | -1.46% |
2023 FY | 2.33 Billion JPY | 37.63% |
2022 Q3 | 1.73 Billion JPY | -0.76% |
2022 Q4 | 1.69 Billion JPY | -2.21% |
2022 FY | 1.69 Billion JPY | 22.47% |
2022 Q1 | 1.52 Billion JPY | 10.18% |
2022 Q2 | 1.74 Billion JPY | 14.53% |
2021 Q1 | 983.45 Million JPY | 5.2% |
2021 Q3 | 1.22 Billion JPY | 5.44% |
2021 Q4 | 1.38 Billion JPY | 12.51% |
2021 FY | 1.38 Billion JPY | 47.91% |
2021 Q2 | 1.16 Billion JPY | 18.51% |
2020 Q3 | 913.41 Million JPY | 8.96% |
2020 Q2 | 838.28 Million JPY | 11.09% |
2020 FY | 934.83 Million JPY | 15.84% |
2020 Q4 | 934.83 Million JPY | 2.35% |
2020 Q1 | 754.59 Million JPY | -6.49% |
2019 Q1 | 657 Million JPY | 7.42% |
2019 FY | 806.97 Million JPY | 31.94% |
2019 Q4 | 806.97 Million JPY | 8.61% |
2019 Q3 | 743.03 Million JPY | 4.15% |
2019 Q2 | 713.42 Million JPY | 8.59% |
2018 Q4 | 611.62 Million JPY | -6.35% |
2018 Q2 | 693.13 Million JPY | 5.72% |
2018 FY | 611.62 Million JPY | -4.09% |
2018 Q3 | 653.09 Million JPY | -5.78% |
2018 Q1 | 655.64 Million JPY | 2.82% |
2017 Q1 | 252.35 Million JPY | -3.17% |
2017 Q4 | 637.68 Million JPY | -9.59% |
2017 FY | 637.68 Million JPY | 144.68% |
2017 Q3 | 705.33 Million JPY | 153.48% |
2017 Q2 | 278.26 Million JPY | 10.27% |
2016 Q2 | 190.79 Million JPY | 2.58% |
2016 Q4 | 260.62 Million JPY | 38.76% |
2016 Q3 | 187.82 Million JPY | -1.56% |
2016 FY | 260.62 Million JPY | 48.87% |
2016 Q1 | 185.99 Million JPY | 6.24% |
2015 FY | 175.06 Million JPY | -20.57% |
2015 Q3 | 221.21 Million JPY | 0.6% |
2015 Q2 | 219.9 Million JPY | 0.33% |
2015 Q1 | 219.19 Million JPY | -0.55% |
2015 Q4 | 175.06 Million JPY | -20.86% |
2014 FY | 220.39 Million JPY | 80.08% |
2014 Q2 | 146.47 Million JPY | 8.28% |
2014 Q4 | 220.39 Million JPY | 25.11% |
2014 Q3 | 176.16 Million JPY | 20.27% |
2014 Q1 | 135.27 Million JPY | 10.53% |
2013 Q2 | 104.91 Million JPY | 29.04% |
2013 Q3 | 116.44 Million JPY | 10.99% |
2013 FY | 122.38 Million JPY | 66.44% |
2013 Q4 | 122.38 Million JPY | 5.1% |
2013 Q1 | 81.3 Million JPY | 10.57% |
2012 FY | 73.53 Million JPY | 38.13% |
2012 Q1 | 59.91 Million JPY | 12.55% |
2012 Q2 | 59.93 Million JPY | 0.03% |
2012 Q3 | 62.75 Million JPY | 4.71% |
2012 Q4 | 73.53 Million JPY | 17.17% |
2011 Q2 | 33.53 Million JPY | -2.94% |
2011 Q4 | 53.23 Million JPY | -5.17% |
2011 FY | 53.23 Million JPY | 55.96% |
2011 Q3 | 56.13 Million JPY | 67.42% |
2011 Q1 | 34.54 Million JPY | 1.21% |
2010 Q1 | 43.65 Million JPY | 0.0% |
2010 FY | 34.13 Million JPY | 0.0% |
2010 Q3 | 39.07 Million JPY | -3.4% |
2010 Q2 | 40.44 Million JPY | -7.34% |
2010 Q4 | 34.13 Million JPY | -12.64% |
2009 Q3 | 67.02 Million JPY | -10.42% |
2009 Q2 | 74.82 Million JPY | -5.17% |
2009 Q1 | 78.9 Million JPY | 12.13% |
2008 FY | 78.9 Million JPY | -30.33% |
2008 Q4 | 70.36 Million JPY | 0.0% |
2007 FY | 113.26 Million JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
KOHJIN BIO CO LTD | 683.01 Million JPY | -241.228% |
PRISM BioLab Co.,LTD | 17.92 Million JPY | -12899.175% |
Linical Co., Ltd. | - JPY | -Infinity% |
Trans Genic Inc. | 2.22 Billion JPY | -4.62% |
MEDINET Co., Ltd. | 67.48 Million JPY | -3353.745% |
Soiken Holdings Inc. | 1.12 Billion JPY | -107.93% |
Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -2151.069% |
AnGes, Inc. | 1.61 Billion JPY | -44.239% |
OncoTherapy Science, Inc. | 73.99 Million JPY | -3049.532% |
Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 19.717% |
Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -623.991% |
NanoCarrier Co., Ltd. | 184 Thousand JPY | -1266542.391% |
Carna Biosciences, Inc. | 140.14 Million JPY | -1563.067% |
CanBas Co., Ltd. | 728 Thousand JPY | -320040.385% |
D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -2552.564% |
RaQualia Pharma Inc. | 147.93 Million JPY | -1475.394% |
Chiome Bioscience Inc. | 64.1 Million JPY | -3535.519% |
Kidswell Bio Corporation | 875.65 Million JPY | -166.158% |
PeptiDream Inc. | 2.4 Billion JPY | 3.059% |
Oncolys BioPharma Inc. | 5.34 Million JPY | -43528.267% |
Ribomic Inc. | 2.27 Million JPY | -102389.974% |
SanBio Company Limited | - JPY | -Infinity% |
Healios K.K. | - JPY | -Infinity% |
BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -233062199900.0% |
Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -6373.95% |
Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
StemRIM | 29 Million JPY | -7936.628% |
CellSource Co., Ltd. | 305.92 Million JPY | -661.828% |
FunPep Company Limited | 25.54 Million JPY | -9025.023% |
Kringle Pharma, Inc. | 364.05 Million JPY | -540.182% |
Stella Pharma Corporation | 1.11 Billion JPY | -108.789% |
TMS Co., Ltd. | 50.02 Million JPY | -4558.915% |
Noile-Immune Biotech Inc. | 20.9 Million JPY | -11050.768% |
Cuorips Inc. | 1.04 Million JPY | -223353.691% |
K Pharma,Inc. | 10.79 Million JPY | -21491.829% |
Takara Bio Inc. | 11.85 Billion JPY | 80.332% |
ReproCELL Incorporated | 248.14 Million JPY | -839.237% |
PhoenixBio Co., Ltd. | 450.58 Million JPY | -417.241% |
StemCell Institute Inc. | 42.26 Million JPY | -5414.699% |
Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -919.676% |
CellSeed Inc. | 46.19 Million JPY | -4945.619% |